Oral ethanol prescribing for alcohol withdrawal syndrome: initial findings and future directions following implementation within a United Kingdom National Health Service setting.

IF 3 3区 医学 Q2 TOXICOLOGY Clinical Toxicology Pub Date : 2024-07-01 Epub Date: 2024-06-24 DOI:10.1080/15563650.2024.2363381
Darren Quelch, Arlene Copland, Jatinder Kaur, Nikhil Sarma, Carol Appleyard, Alan Nevill, Nyle Davies, Thomas Knight, Grace Williams, Gareth Roderique-Davies, Bev John, Sally Bradberry
{"title":"Oral ethanol prescribing for alcohol withdrawal syndrome: initial findings and future directions following implementation within a United Kingdom National Health Service setting.","authors":"Darren Quelch, Arlene Copland, Jatinder Kaur, Nikhil Sarma, Carol Appleyard, Alan Nevill, Nyle Davies, Thomas Knight, Grace Williams, Gareth Roderique-Davies, Bev John, Sally Bradberry","doi":"10.1080/15563650.2024.2363381","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Prescribing of ethanol may be an alternative to benzodiazepines for managing alcohol withdrawal syndrome. We present our experience of oral ethanol prescribing within an acute United Kingdom National Health Service setting.</p><p><strong>Methods: </strong>A retrospective review of patients presenting with alcohol withdrawal who were managed with oral ethanol or benzodiazepines was performed from data collected across two acute care settings. Ethanol prescribing inclusion: high risk of delirium tremens, <b>or</b> a history of harmful alcohol consumption (typically ≥30 units/day; in which 1 unit = 8 grams of alcohol; one standard United States drink = 14 grams of alcohol) <b>or</b> known to have a history of severe alcohol withdrawal, alcohol-related seizures or delirium tremens. Inverse propensity score weighting was used to partially account for variance between the two patient populations.</p><p><strong>Results: </strong>Fifty (82 per cent male; average age 50.9 years) and 93 (84 per cent male; average age 46.5 years) patients in receipt of benzodiazepines or ethanol, respectively, were included. The likelihood of hospital admission was significantly reduced when individuals were managed with ethanol (odds ratio 0.206 (95 per cent confidence interval; 0.066-0.641), Wald chi-square <i>P</i> = 0.006). In those not admitted, the treatment type had no significant impact on length of stay or the number of occasions a pharmacological agent was required. In those admitted, treatment had no significant effect on length of stay.</p><p><strong>Discussion: </strong>We offer preliminary evidence to support a role of oral ethanol in the management of patients with alcohol withdrawal. We have implemented a robust and translatable guideline. Despite limitations in the data set the impact of ethanol in reducing the likelihood of admission remained significant.</p><p><strong>Conclusions: </strong>In individuals at significant risk of severe alcohol withdrawal, prescribing ethanol as part of a comprehensive care plan, may reduce unplanned admissions. The preliminary findings presented here warrant further assessment through prospective studies.</p>","PeriodicalId":10430,"journal":{"name":"Clinical Toxicology","volume":" ","pages":"432-440"},"PeriodicalIF":3.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Toxicology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/15563650.2024.2363381","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/24 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"TOXICOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Prescribing of ethanol may be an alternative to benzodiazepines for managing alcohol withdrawal syndrome. We present our experience of oral ethanol prescribing within an acute United Kingdom National Health Service setting.

Methods: A retrospective review of patients presenting with alcohol withdrawal who were managed with oral ethanol or benzodiazepines was performed from data collected across two acute care settings. Ethanol prescribing inclusion: high risk of delirium tremens, or a history of harmful alcohol consumption (typically ≥30 units/day; in which 1 unit = 8 grams of alcohol; one standard United States drink = 14 grams of alcohol) or known to have a history of severe alcohol withdrawal, alcohol-related seizures or delirium tremens. Inverse propensity score weighting was used to partially account for variance between the two patient populations.

Results: Fifty (82 per cent male; average age 50.9 years) and 93 (84 per cent male; average age 46.5 years) patients in receipt of benzodiazepines or ethanol, respectively, were included. The likelihood of hospital admission was significantly reduced when individuals were managed with ethanol (odds ratio 0.206 (95 per cent confidence interval; 0.066-0.641), Wald chi-square P = 0.006). In those not admitted, the treatment type had no significant impact on length of stay or the number of occasions a pharmacological agent was required. In those admitted, treatment had no significant effect on length of stay.

Discussion: We offer preliminary evidence to support a role of oral ethanol in the management of patients with alcohol withdrawal. We have implemented a robust and translatable guideline. Despite limitations in the data set the impact of ethanol in reducing the likelihood of admission remained significant.

Conclusions: In individuals at significant risk of severe alcohol withdrawal, prescribing ethanol as part of a comprehensive care plan, may reduce unplanned admissions. The preliminary findings presented here warrant further assessment through prospective studies.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
口服乙醇治疗酒精戒断综合征:在英国国民健康服务机构实施后的初步发现和未来方向。
导言:开具乙醇处方可以替代苯二氮卓类药物治疗酒精戒断综合征。我们介绍了在英国国民健康服务机构的急诊环境中口服乙醇的经验:方法:根据在两个急症医疗机构收集到的数据,对接受口服乙醇或苯二氮卓治疗的酒精戒断患者进行回顾性分析。乙醇处方纳入条件:震颤性谵妄风险高,或有有害酒精消费史(通常≥30单位/天;其中1单位=8克酒精;1杯美国标准饮料=14克酒精),或已知有严重酒精戒断、酒精相关性癫痫发作或震颤性谵妄史。采用反倾向评分加权法来部分考虑两个患者群体之间的差异:分别纳入了 50 名(82% 为男性;平均年龄 50.9 岁)和 93 名(84% 为男性;平均年龄 46.5 岁)接受苯二氮卓类药物或乙醇治疗的患者。接受乙醇治疗的患者入院的可能性明显降低(几率比 0.206(95% 置信区间;0.066-0.641),Wald chi-square P = 0.006)。在未入院的患者中,治疗类型对住院时间或需要使用药剂的次数没有明显影响。在住院患者中,治疗对住院时间没有明显影响:讨论:我们提供的初步证据支持口服乙醇在酒精戒断患者的治疗中发挥作用。我们实施了一项稳健且可转化的指南。尽管数据集存在局限性,但乙醇在降低入院可能性方面的作用仍然显著:结论:对于有严重酒精戒断风险的患者,作为综合治疗计划的一部分,处方乙醇可减少意外入院。本文介绍的初步研究结果值得通过前瞻性研究进行进一步评估。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical Toxicology
Clinical Toxicology 医学-毒理学
CiteScore
5.70
自引率
12.10%
发文量
148
审稿时长
4-8 weeks
期刊介绍: clinical Toxicology publishes peer-reviewed scientific research and clinical advances in clinical toxicology. The journal reflects the professional concerns and best scientific judgment of its sponsors, the American Academy of Clinical Toxicology, the European Association of Poisons Centres and Clinical Toxicologists, the American Association of Poison Control Centers and the Asia Pacific Association of Medical Toxicology and, as such, is the leading international journal in the specialty.
期刊最新文献
Correction. Ethanol for the management of alcohol withdrawal syndrome: a systematic review. A 10-year retrospective review of exposures to volatile nitrites reported to the Victorian Poisons Information Centre. Response to West et al. "Identifying and quantifying exposures involving counterfeit opioid analgesic products". Augmenting the sensitivity for hepatotoxicity prediction in acute paracetamol overdose: combining psi (ψ) parameter and paracetamol concentration aminotransferase activity multiplication product.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1